How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
We calculated all-in costs including medication, consultations, and shipping
Rare Risk of Delayed Gastric Emptying: Although uncommon, some individuals may experience slowed digestion, affecting nutrient absorption and overall comfort
Our expert team at Ovation Med Spa is ready to create a personalized GLP-1 treatment plan just for you
Aqu encontrars una visin completa para que tu primera experiencia resulte fluida, segura y entretenida, desde la verificacin de tu cuenta hasta la seleccin del ttulo ideal, pasando por la gestin responsable de tu presupuesto
facility to the highest standards, from formulation to final packaging